ホームSTAR • NSE
add
Strides Pharma Science Ltd
前日の終値
₹1,643.30
日次変動幅
₹1,593.55 - ₹1,654.95
年間変動幅
₹467.00 - ₹1,675.00
時価総額
1497.91億 INR
平均取引高
34.95万
株価収益率
3,343.12
配当利回り
0.15%
優先市場
NSE
市場ニュース
財務情報
損益計算書
収益
純利益
(INR) | 2024年6月info | 前年比変化率 |
---|---|---|
収益 | 108.75億 | 16.94% |
営業費用 | 49.87億 | 13.84% |
純利益 | 7.02億 | 1,086.95% |
純利益率 | 6.46 | 950.00% |
1 株当たりの収益 | — | — |
EBITDA | 22.36億 | 33.22% |
実効税率 | 19.80% | — |
貸借対照表
総資産
負債総額
(INR) | 2024年6月info | 前年比変化率 |
---|---|---|
現金および短期投資 | 29.69億 | -19.05% |
総資産 | — | — |
負債総額 | — | — |
純資産 | 207.17億 | — |
発行済み株式 | 9188.74万 | — |
帳簿価格 | 7.10 | — |
総資産利益率 | — | — |
資本利益率 | 9.17% | — |
キャッシュ フロー
現金の純増減額
(INR) | 2024年6月info | 前年比変化率 |
---|---|---|
純利益 | 7.02億 | 1,086.95% |
営業キャッシュ フロー | — | — |
投資キャッシュ フロー | — | — |
財務キャッシュ フロー | — | — |
現金の純増減額 | — | — |
フリー キャッシュ フロー | — | — |
概要
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
設立
1990
本社所在地
ウェブサイト
従業員数
3,065